Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

Clinical trial NCT03114462 · RECRUITING

Trial details

NCT number: NCT03114462
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasms of Respiratory and Intrathoracic Organs Squamous Cell Carcinoma of the Larynx

Start date: 2017-08-09
Primary completion: 2027-06-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.